7 completed, 1 terminated. 4 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow ZS Pharma, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study Hyperkalemia | Completed | ZS Pharma, Inc. | 203 | 2015-10-31 | 2017-06-08 | |
| POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study Cardiac rhythm remote monitoring system - Hyperkalemia | Completed | ZS Pharma, Inc. | 240 | 2015-09-30 | 2017-07-25 | |
| Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months Sodium Zirconium Cyclosilicate - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 751 | 2014-06-30 | 2018-06-27 |
| Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia. Sodium Zirconium Cyclosilicate - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 123 | 2014-05-31 | 2018-08-15 |
| Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia. Sodium zirconium cyclosilicate, Placebo - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 258 | 2014-03-31 | 2018-12-07 |
| Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia Sodium polystyrene sulfonate, Silicified microcrystalline cellulose - Hyperkalemia | Phase 4 | Terminated | ZS Pharma, Inc. | 32 | 2013-05-01 | 2014-09-03 |
| Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia Zirconium silicate (acute phase), Zirconium silicate (subacute phase), Placebo (acute phase) - Hyperkalemia | Phase 3 | Completed | ZS Pharma, Inc. | 754 | 2012-11-30 | 2018-10-12 |
| Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia Zirconium silicate (ZS), Placebo - Hyperkalemia, Chronic Kidney Disease | Phase 2 | Completed | ZS Pharma, Inc. | 90 | 2011-11-30 | 2018-06-29 |
Hyperkalemia (8) · Renal Insufficiency, Chronic (1)
sodium zirconium cyclosilicate (3) · zircon (3) · polystyrene sulfonic acid (1)
United States (8) · Australia (4) · South Africa (3) · Germany (1) · Netherlands (1) · Romania (1) · United Kingdom (1)
Henrik Rasmussen, MD, PhD (5) · Henrik Rasmussen, MD (3)
PMID 32588430, PMID 31791288, PMID 25402495, PMID 25415807, PMID 29728199, PMID 32030422